Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Ion-ARPA initiative

Ionis Pharmaceuticals

Ion-ARPA is an initiative to identify next-wave technologies with the potential to accelerate the creation of therapeutic technologies through disruptive innovation. Modeled on the U.S. Department of Defense program known as DARPA (Defense Advanced Research Projects Agency), the Ion-ARPA approach will contribute to Ionis’ long-term strategy by expanding on the innovation that brought about its revolutionary antisense technology to create novel cutting-edge technologies capable of pioneering new markets in healthcare. Ion-ARPA programs will be funded (up to $1M per laboratory) based on high-risk ideas with big payoff potential.

New Opportunities for 2023

Proposals to obtain proof of principle for an extraordinarily novel idea will be considered for funding up to $500,000 (total direct and indirect costs)/year for up to two years on a rolling basis at any time.

Area of interest #1: New delivery strategies that enable delivery of large nucleic acid payloads to the CNS

There are many opportunities to treat diseases in the CNS, but methods to deliver large nucleic acids to appropriate cells in the CNS are limiting. We are seeking proposals for unconventional approaches (excluding AAV or other live viruses, and beyond the ideas currently in the literature) to deliver large therapeutic payloads to cells of the CNS.

Area of interest #2: New strategies for regulating the epigenome for therapeutics

Epigenome editing has emerged as a therapeutic strategy to regulate gene expression without creating nicks or breaks in the DNA. We are interested in funding novel strategies to provide long lasting epigenome modulation to increase or decrease expression of gene products. We are not interested in using replicating viruses (e.g. AAV), editing RNA or ideas based on dead Cas similar to what is in the literature already. We are only interested in funding completely novel approaches.

If you are interested in submitting a proposal, please submit a white paper (5 pages maximum) that succinctly describes your idea. Use the standard white paper template and submit to Ion-ARPA@ionisph.com.

Specialties

Medical

Medical - Clinical Science

Medical - Basic Science

Eligibility Requirements

Investigators from academic institutions, companies, national laboratories, nonprofit institutes, and multi-institutional teams are welcome to apply.

Sponsor Details

Sponsor Institute/Organizations: Ionis Pharmaceuticals

Sponsor Type:

Address: NA

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity